Cargando…

Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is required. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tosev, Georgi, Wahafu, Wasilijiang, Reimold, Philipp, Damgov, Ivan, Schwab, Constantin, Aksoy, Cem, Kaczorowski, Adam, Stenzinger, Albrecht, Nyarangi-Dix, Joanne, Hohenfellner, Markus, Duensing, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270894/ https://www.ncbi.nlm.nih.gov/pubmed/34244564 http://dx.doi.org/10.1038/s41598-021-93754-z

Ejemplares similares

Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

Intravenous pyogenic granuloma of the renal vein: A rare morphological differential diagnosis to renal cell carcinoma
por: Philipp, Reimold, et al.
Publicado: (2019)

Hydronephrotic pelvic kidney mimicking urinary retention in an 18-year-old male
por: Reimold, Philipp, et al.
Publicado: (2022)

Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
por: Görtz, Magdalena, et al.
Publicado: (2022)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery
por: Schuetz, Viktoria, et al.
Publicado: (2021)

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma
por: Schneider, Felix, et al.
Publicado: (2023)

Better Knowledge about Testicular Cancer Might Improve the Rate of Testicular (Self-)Examination: A Survey among 1,025 Medical Students in Germany
por: Aksoy, Cem, et al.
Publicado: (2022)

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
por: Friedhoff, Jana, et al.
Publicado: (2022)

Intracardiac Extension of Wilms Tumor: A Case of a 2.5-Year-Old Girl Presenting with Upper Venous Congestion Caused by Tumor Growth into the Right Cardiac Ventricle
por: Imle, Roland, et al.
Publicado: (2019)

Hypospadias
por: Djakovic, N., et al.
Publicado: (2008)

Increased H(2)S and its synthases in urothelial cell carcinoma of the bladder, and enhanced cisplatin-induced apoptosis following H(2)S inhibition in EJ cells
por: Wahafu, Wasilijiang, et al.
Publicado: (2018)

Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer
por: Nyarangi-Dix, Joanne Nyaboe, et al.
Publicado: (2019)

Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
por: Li, Jielin, et al.
Publicado: (2021)

Significance of the Intraoperative Methylene Blue Test for Postoperative Evaluation of the Vesicourethral Anastomosis
por: Nyarangi-Dix, J. N., et al.
Publicado: (2012)

Genomic features of renal cell carcinoma with venous tumor thrombus
por: Warsow, Gregor, et al.
Publicado: (2018)

Detection Rate of Prostate Cancer in Repeat Biopsy after an Initial Negative Magnetic Resonance Imaging/Ultrasound-Guided Biopsy
por: Görtz, Magdalena, et al.
Publicado: (2023)

Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer
por: Hatiboglu, G., et al.
Publicado: (2017)

The BRCA2 mutation status shapes the immune phenotype of prostate cancer
por: Jenzer, Maximilian, et al.
Publicado: (2019)

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities
por: Pohl, Laura, et al.
Publicado: (2022)

Paraganglioma of the Seminal Vesicle Case Report and Review of the Literature
por: Tosev, Georgi, et al.
Publicado: (2016)

Mutations in BRCA2 and taxane resistance in prostate cancer
por: Nientiedt, Cathleen, et al.
Publicado: (2017)

Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS
por: Radtke, Jan Philipp, et al.
Publicado: (2019)

Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells
por: Gai, Jun-Wei, et al.
Publicado: (2018)

Biotransformation of Abiraterone Into Five Characteristic Metabolites by the Rat Gut Microbiota and Liver Microsomes
por: Keranmu, Adili, et al.
Publicado: (2022)

Urothelial ATP exocytosis: regulation of bladder compliance in the urine storage phase
por: Nakagomi, Hiroshi, et al.
Publicado: (2016)

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy
por: Dietz, Steffen, et al.
Publicado: (2017)

miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells
por: Bauer, Simone, et al.
Publicado: (2021)

Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer
por: Schwarz, Sebastian, et al.
Publicado: (2023)

Primary melanoma of the prostate: case report and review of the literature
por: Tosev, Georgi, et al.
Publicado: (2015)

Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
por: Schwab, Constantin, et al.
Publicado: (2022)

The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
por: Wahafu, Wasilijiang, et al.
Publicado: (2019)

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
por: Humayun-Zakaria, Nada, et al.
Publicado: (2021)

Feasibility of single position laparoscopic radical nephrectomy and tumor thrombectomy for left renal cell carcinoma with high-risk Mayo grade 0 and 1 tumor thrombus
por: Keranmu, Adili, et al.
Publicado: (2021)

Modified ileal conduit intracorporeally accomplished following laparoscopic radical cystectomy with enhanced recovery protocols: experience with 48 cases
por: Wei, Houyi, et al.
Publicado: (2021)

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
por: Hoefflin, Rouven, et al.
Publicado: (2016)

Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study
por: Seydel, Florian, et al.
Publicado: (2021)

Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities
por: Flezar, Margareta Strojan
Publicado: (2010)

Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA
por: Lee, Dongin, et al.
Publicado: (2023)

Significance of pigmented urothelial and non-urothelial cells in voided urine specimens: A case report and review
por: Kagan, Joseph Alan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dbfdkleic4c31n0g2s85douqi9